Resident Accolades

Byrd HF, Luo G, Crosswhite B, Emeka-Ibe G, Davis T, Whitaker R. Stereotactic Radiosurgery to the Nucleus Accumbens: A Dosimetric Feasibility Study. *Cureus*. 2025 Jul 18;17(7):e88231.

Lu M, Byrd H, Chen H, Iams W. Brief Report: Relationship Between Tumor Volume and Clinical Outcomes in Relapsed Small Cell Lung Cancer. *JTO Clinical and Research Reports*. 2025 Sep.

Byrd H, Kessler M, Sosa G, Emeka-Ibe G, Penn C, Brown A, Prescott L, Crispens M, Alvarez RD, Shinde A. Comparison of Vaginal Stenosis Following Vault Brachytherapy Monotherapy between Common Fractionation Schemes in the Treatment of Endometrial Cancer. *Brachytherapy*. 2025.

Byrd HF, Kohutek ZA. Painful Realities: Navigating the Complexities of Head and Neck Cancer Pain. *Oral Dis*. 2024 Oct 7.

Gracie J, Jimenez R, Winkfield KM. The Burden of Insurance Prior Authorization on Cancer Care: A Review of Evidence From Radiation Oncology. *Adv Radiat Oncol*. 2024 Oct 23;10(1):101654.

Gracie JR, Whitaker R. Treatment-Refractory Scleredema Diabeticorum Managed With Re-irradiation Using Volumetric Modulated Arc Therapy. *Cureus*. 2024 Sep 12;16(9):e69279.

Gracie J, Holtzman AL, Dagan R, Bryant CM, Morris CG, Mendenhall WM. Impact of mandated drug monitoring on opioid use during highly conformal radiotherapy for oropharynx cancer. *Ann Palliat Med*. 2023 Nov;12(6):1146-1154.

Kline-Quiroz C, Byrd H, Dovgan J, et al. Pathophysiology of Radiation Fibrosis Syndrome. *Curr Phys Med Rehabil Rep*. 2023;11(3):325–334.

Ahmed HZ, Nittala MR, Kosalram N, Crosswhite B, Lee AP, Frazier TC, Milner CP, Vijayakumar S. Patients and Families' Participation in Multidisciplinary Tumor Conferences Improves Patient and Family-Focused Cancer Care: Lessons Learned From a Debate on the Role of Radiation Therapy in Primary Mediastinal Non-Hodgkin Lymphoma. *Cureus*. 2023 Feb 6;15(2):e34693.

10. Bradley JA, Gracie J, Mailhot Vega RB, Brooks ED, Burchianti T, Oladeru OT, Liang X, Mendenhall NP. Proton Therapy in the Treatment of Men with Breast Cancer. *Int J Part Ther*. 2023 Oct 25;10(2):94-104.

Gracie J, Fortune EC 4th, Morris CG, Leach DF 3rd, Mendenhall WM. Radiation Treatment for Cancer of the Anal Margin. *Am J Clin Oncol*. 2023 Apr 1;46(4):167-171.

Azhar M, Kincaid Z, Kesarwani M, Menke J, Schwieterman J, Ansari S, Reaves A, Ahmed A, Shehzad R, Khan A, Syed N, Amir N, Wunderlich M, Latif T, Seibel W, Azam M. Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML. *Blood Adv*. 2023 Apr 25;7(8):1460-1476.

Kessler MR, Dove AP, Kirschner AN. Radiation Fibrosis After Stereotactic Body Radiation Therapy for Osseous Metastases: A Case Report. *Cureus*. 2022 Sep;14(9):e28925.

Bates AM, Brown RJ, Pieper AA, Zangl LM, Arthur I, Carlson PM, Le T, Sosa GA, Clark PA, Sriramaneni RN, Kim K, Patel RB, Morris ZS. Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer. *Front Oncol*. 2021 Apr 15;11:645352.

Leonetti JP, Weishaar JR, Gannon D, Harmon GA, Block A, Anderson DE. Osteoradionecrosis of the skull base. *J Neurooncol*. 2020 Dec;150(3):477-482.

Gu M, Shao NY, Sa S, Li D, Termglinchan V, Ameen M, Karakikes I, Sosa G, Grubert F, Lee J, Cao A, Taylor S, Ma Y, Zhao Z, Chappell J, Hamid R, Austin ED, Gold JD, Wu JC, Snyder MP, Rabinovitch M. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. *Cell Stem Cell*. 2016 Dec 1;19(6):804-816.

• MOBILE: Mitigating Osteoarthritis by Intervention with Low-Dose Irradiation to Extremities
  • Investigators: Dr. Austin Dove (PI), Dr. Austin Kirschner, Dr. Tony Cmelak, Dr. Ryan Whitaker, Dr. Ashwin Shinde
• VMAT: Vertebral Bone Marrow in Lung Cancer Attention Trial
  • Investigators: Dr. Evan Osmundson (Co-PI), Dr. Neil Newman (Co-PI, former resident), Dr. Austin Dove
• Utilization of 18F-FGln PET/CT Imaging in Metastatic Renal Cell Carcinoma.
  • Investigators: Dr. Dakim Gaines, Dr. WK Rathmell, Dr. BI Rini. 2020.
• The relationship between tumor hypoxia, tumor recurrence, and radiation necrosis in patients with brain metastases undergoing stereotactic radiosurgery for local control. 2022
  • Investigators: Dr. Jill De Vis, Dr. Evan Osmundson, Dr. MJ Donahue.
• TESSERACT: Trial in ES-SCLC Enhancing Response to Atezolizumab and Chemotherapy with Total Body Irradiation.
  • Investigators: Dr. Ryan Whitaker, Dr. Dakim Gaines, Dr. Evan Osmundson, 2020.
• IST-370: Phase I/II Clinical Trial Evaluating the Role of Selinexor in Locally Advanced Rectal Cancer Treatment (SELECT).
  • Co-Investigator: Dr. Ryan Whitaker
• SICARIO: Phase I/II Trial of Split-Course Adaptive Radioimmunotherapy for the Treatment of Oligometastatic Non-Small Cell Lung Cancer using Biologically-Adaptive Radiotherapy.
  • Investigator: Dr. Ryan Whitaker 

• NIH NLM T15 Training Grant, to pursue Masters in Clinical Bioinformatics, 2022 - 2024
  • Dr. Samuel Jean-Baptiste
• NIH R21, $250,000 Direct Costs, 2022
  • Dr. Jill De Vis
• AACR-Clinical Oncology Research (CORE) Training Fellowship, 2923 $100,000
  • Dr. Ha Pham
• ASTRO Advocacy Day Travel Grant Recipient
  • Dr. Kyra McComas, Dr. Jayden Gracie
• Vanderbilt Institute for Clinical and Translational Research (VICTR) Grant Total $5,000
  • Dr. Austin Dove
• ​​​ECOG-ACRIN Travel Scholarship Award, 2023
  • Dr. Samuel Jean-Baptiste
• ACRO Travel Scholarship Award, 2024 - 2025
  • Dr. Jayden Gracie
• ASCO Conquer Cancer Merit Award, 2025
  • Dr. Jayden Gracie
• Vanderbilt Institute for Clinical and Translational Research (VICTR) Grant Total $5,000
  • Dr. Hayden Byrd